Method for producing a drug delivery system
Inventors
Schneeberger, Achim • Kühne, Klaus • KERSCHBAUMER, Helmut • VASIC, Srdan
Assignees
Exentis Knowledge GmbH • Exentis Knowldege GmbH • Laxxon Medical AG
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
The present invention relates to a method for producing a drug delivery system. The method comprises the steps of screen-printing a base paste, and curing the base paste. Furthermore, the method comprises the steps of screen-printing a first paste separate to the base paste, and curing the first paste.
Core Innovation
The invention relates to a method for producing a drug delivery system by screen-printing and curing a base paste and a screen-printed, cured first paste separate to the base paste. The first paste comprises a therapeutically effective amount of a first active pharmaceutical ingredient, and the base paste and the first paste are soluble in body fluids so that the resulting drug delivery system is soluble in body fluids.
The method provides a three-dimensional body formed by the base paste, and the separate first paste is inhomogeneously arranged throughout the base paste along the three dimensions. This arrangement produces an inhomogeneous concentration profile in the resulting drug delivery system, where transitions from a high API concentration area to a low API concentration area are smooth.
The concentration profile of the first API is selected to yield predetermined release profiles, including release at varying rates and, in particular implementations, constant-rate sections. Additional aspects include release profiles with multi-dosage release timings, and optional sequential or intermittent release of multiple APIs by screen-printing and curing additional pastes containing therapeutically effective amounts of different APIs.
Claims Coverage
The partial claim set provided includes one independent claim. The main inventive features are directed to forming a body-fluid-soluble drug delivery system by screen-printing and curing separate pastes with an inhomogeneous, smooth concentration profile that yields varying-rate release of a first API, which is an anti-infective agent.
Separate screen-printed and cured pastes forming a body-fluid-soluble drug delivery system
Screen-printing a base paste, curing the base paste, screen-printing a first paste separate to the base paste, and curing the first paste, wherein the first paste comprises a therapeutically effective amount of a first API and wherein the base paste and the first paste are soluble in body fluids so that the resulting drug delivery system is soluble in body fluids.
Three-dimensional inhomogeneous arrangement of the first paste in the base paste
The base paste is provided as a three-dimensional body and the separate first paste is inhomogeneously arranged throughout the base paste along the three dimensions.
Spatially varying first API concentration with smooth high-to-low transitions
The concentration of the first API varies throughout the drug delivery system, and a transition from an area with a high API concentration to an area with a low API concentration is smooth.
Varying-rate release determined by the concentration profile
The concentration profile of the first API is such that upon application of the drug delivery system the release of the first API occurs at a varying rate.
Anti-infective first API
The first API is an anti-infective agent.
Coverage centers on producing a body-fluid-soluble drug delivery system using separate screen-printed and cured pastes that create a three-dimensional, inhomogeneous, smooth spatial concentration profile of an anti-infective first API, resulting in varying-rate release upon application.
Stated Advantages
Not explicitly described in patent.
Documented Applications
Not explicitly described in patent.
Interested in licensing this patent?